Aptevo Therapeutics Inc (APVO)
0.751
-0.03
(-3.72%)
USD |
NASDAQ |
May 22, 16:00
0.746
0.00 (0.00%)
After-Hours: 05:54
Aptevo Therapeutics Research and Development Expense (Quarterly): 3.752M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.752M |
| December 31, 2023 | 3.591M |
| September 30, 2023 | 3.887M |
| June 30, 2023 | 5.462M |
| March 31, 2023 | 4.168M |
| December 31, 2022 | 4.674M |
| September 30, 2022 | 4.477M |
| June 30, 2022 | 3.865M |
| March 31, 2022 | 4.866M |
| December 31, 2021 | 4.543M |
| September 30, 2021 | 4.367M |
| June 30, 2021 | 4.722M |
| March 31, 2021 | 5.362M |
| December 31, 2020 | 4.912M |
| September 30, 2020 | 4.494M |
| June 30, 2020 | 4.44M |
| March 31, 2020 | 4.006M |
| December 31, 2019 | 4.408M |
| September 30, 2019 | 7.596M |
| Date | Value |
|---|---|
| June 30, 2019 | 6.125M |
| March 31, 2019 | 6.634M |
| December 31, 2018 | 8.899M |
| September 30, 2018 | 8.574M |
| June 30, 2018 | 9.713M |
| March 31, 2018 | 8.199M |
| December 31, 2017 | 9.186M |
| September 30, 2017 | 7.175M |
| June 30, 2017 | 6.787M |
| March 31, 2017 | 5.873M |
| December 31, 2016 | 6.361M |
| September 30, 2016 | 7.077M |
| June 30, 2016 | 7.636M |
| March 31, 2016 | 8.101M |
| December 31, 2015 | 7.407M |
| September 30, 2015 | 7.712M |
| June 30, 2015 | 10.51M |
| March 31, 2015 | 9.101M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.591M
Minimum
Dec 2023
7.596M
Maximum
Sep 2019
4.686M
Average
4.486M
Median
Research and Development Expense (Quarterly) Benchmarks
| Heron Therapeutics Inc | 4.608M |
| Creative Medical Technology Holdings Inc | 0.4224M |
| BioSig Technologies Inc | 0.238M |
| Adial Pharmaceuticals Inc | 0.4543M |
| IN8bio Inc | 4.903M |